Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2022 | 2 |
2023 | 1 |
2024 | 0 |
Search Results
3 results
Results by year
Filters applied: . Clear all
Page 1
Breast Cancer Statistics in Korea, 2019.
J Breast Cancer. 2023 Jun;26(3):207-220. doi: 10.4048/jbc.2023.26.e27.
J Breast Cancer. 2023.
PMID: 37387348
Free PMC article.
Review.
Stable nebulization and muco-trapping properties of regdanvimab/IN-006 support its development as a potent, dose-saving inhaled therapy for COVID-19.
McSweeney MD, Stewart I, Richardson Z, Kang H, Park Y, Kim C, Tiruthani K, Wolf W, Schaefer A, Kumar P, Aurora H, Hutchins J, Cho JM, Hickey AJ, Lee SY, Lai SK.
McSweeney MD, et al.
Bioeng Transl Med. 2022 Aug 30;8(1):e10391. doi: 10.1002/btm2.10391. Online ahead of print.
Bioeng Transl Med. 2022.
PMID: 36248234
Free PMC article.
Item in Clipboard
The Significance of p-AKT1 as a Prognostic Marker and Therapeutic Target in Patients With Hormone Receptor-Positive and Human Epidermal Growth Factor Receptor-2-Positive Early Breast Cancer.
Kim JY, Park CS, Jang SK, Seol H, Seong MK, Noh WC, Park IC, Kim HA.
Kim JY, et al.
J Breast Cancer. 2022 Oct;25(5):387-403. doi: 10.4048/jbc.2022.25.e43.
J Breast Cancer. 2022.
PMID: 36314765
Free PMC article.
Item in Clipboard
Cite
Cite